Literature DB >> 10841710

Gene therapy on trial.

E Marshall.   

Abstract

Keywords:  Biomedical and Behavioral Research; Genetics and Reproduction; Recombinant DNA Advisory Committee

Mesh：

Substances：

Year:  2000        PMID： 10841710

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  31 in total

Review 1.  The promise and potential hazards of adenovirus gene therapy.

Authors:  L S Young; V Mautner
Journal:  Gut       Date:  2001-05       Impact factor: 23.059

2.  Tumor immunotherapy: inching toward the finish line.

Authors:  Tyler J Curiel; David T Curiel
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

Review 3.  Targeting site-specific chromosome integration.

Authors:  Patricia Nuno-Gonzalez; Hsu Chao; Kazuhiro Oka
Journal:  Acta Biochim Pol       Date:  2005-06-03       Impact factor: 2.149

4.  piggyBac is a flexible and highly active transposon as compared to sleeping beauty, Tol2, and Mos1 in mammalian cells.

Authors:  Sareina Chiung-Yuan Wu; Yaa-Jyuhn James Meir; Craig J Coates; Alfred M Handler; Pawel Pelczar; Stefan Moisyadi; Joseph M Kaminski
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-27       Impact factor: 11.205

5.  Computational and analytical modeling of cationic lipid-DNA complexes.

Authors:  Oded Farago; Niels Grønbech-Jensen
Journal:  Biophys J       Date:  2007-01-26       Impact factor: 4.033

Review 6.  Therapeutic application of RNAi: is mRNA targeting finally ready for prime time?

Authors:  Dirk Grimm; Mark A Kay
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

Review 7.  Combining topographical and genetic cues to promote neuronal fate specification in stem cells.

Authors:  Erin K Purcell; Youssef Naim; Amy Yang; Michelle K Leach; J Matthew Velkey; R Keith Duncan; Joseph M Corey
Journal:  Biomacromolecules       Date:  2012-10-26       Impact factor: 6.988

8.  Gene therapy: ethical issues.

Authors:  Isaac Rabino
Journal:  Theor Med Bioeth       Date:  2003

Review 9.  Gene therapy for renal disorders: what are the benefits for the elderly?

Authors:  Yeong-Hau H Lien; Li-Wen Lai
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

10.  Reengineered salivary glands are stable endogenous bioreactors for systemic gene therapeutics.

Authors:  Antonis Voutetakis; Marc R Kok; Changyu Zheng; Ioannis Bossis; Jianghua Wang; Ana P Cotrim; Natanya Marracino; Corinne M Goldsmith; John A Chiorini; Y Peng Loh; Lynnette K Nieman; Bruce J Baum
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-20       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.